L ow back pain (LBP) is one of the most common symptoms prompting a health care visit in the United States, accounting for about 5% of all physician visits. 1, 2 LBP is the third costliest medical condition in the United States, behind only diabetes and heart disease; and over the past 10 years, the cost of treating LBP has risen at a rate exceeded only by diabetes. 3 Despite increasing financial resources devoted to the management of LBP, prevalence rates are rising and patient-centered outcomes are not improving. [4] [5] [6] A potential explanation for these poor outcomes is poor implementation of clinical practice guidelines and effective care pathways. US and international practice guidelines and care pathways for LBP management are generally consistent in recommendations for diagnostic imaging, nonpharmacologic interventions, and referral to specialist providers. [7] [8] [9] [10] Education, exercise, manual therapy, and other evidence-based nonpharmacologic interventions are supported as initial therapeutic options. 11, 12 Imaging, particularly advanced imaging (ie, MRI or CT), is not recommended except for a few patients with specific symptoms. 13 Referral to specialists for consideration of invasive procedures (eg, epidural injections, surgery) is recommended only for patients with persistent symptoms who do not respond to initial treatment. 9, 14 Yet despite unequivocal recommendations to the contrary, the use of low-value, high-cost procedures including advanced imaging, epidural injections, and surgical intervention has continued to increase. [15] [16] [17] Persistent escalations in low-value care and higher costs without improved patient outcomes represent a failure of health care systems to implement care processes that promote guideline-concordant LBP care. 18 Particularly concerning is increasing evidence that health care costs and use are often "front-loaded," in clear contradiction of evidence-based guidelines. 19, 20 Research in our own region, and using national databases, demonstrates high rates of advanced imaging, specialist physician referrals, and invasive procedures soon after a patient with LBP begins seeking health care. 19, 21, 22 Too often this occurs without efforts first to provide recommended therapeutic options including patient education, exercise, and manual therapy. 23, 24 These interventions are typically provided by physical therapists, yet many patients within health care systems receive escalated care (advanced imaging, specialist referrals, invasive procedures) without first receiving care from a physical therapist. 25, 26 
Development of the RapidAccess Program
University of Utah Health (UUH) is an integrated academic health care system based in Salt Lake City, Utah. In 2014, UUH adopted a clinical pathway intended to better align LBP care with established evidence-based standards as outlined above. 14, 27 One area of care in UUH frequently inconsistent with the recommended pathway was the relationship between physiatry and physical therapy. Patients with LBP were often referred to physiatry following a primary care visit for LBP, or directly entered care with a physiatrist. 22 Many were then referred to physical therapy. This represented an inefficient pathway associated with increased use of lowvalue care, including advanced imaging and injections, and longer episodes of care due to appointment waiting times. 22 A work group of stakeholders was formed that included those with a role in addressing concerns that the LBP care pathway within UUH too often unnecessarily placed physiatry consultation before physical therapy. This work group included a frontline physical therapist and physiatrist, physical therapy and physiatry clinic managers, patient scheduling staff, informatics support, and academic physical therapists with expertise in implementation science. The work group developed a RapidAccess pathway emphasizing physical therapist management before physiatry consultation for appropriate patients. Physiatry consultation was reserved for patients requiring additional care. After several meetings aimed at identifying and overcoming the potential barriers to implementation, a RapidAccess clinical pathway was developed with implementation beginning in January 2016 (Fig. 1) .
Framework for Evaluating Implementation of the RapidAccess Program
We grounded our evaluation of implementing RapidAccess within a RE-AIM framework. RE-AIM defines 5 key elements for sustainable implementation of behavioral health interventions: Reach, Effectiveness, Adoption, Implementation, and Maintenance. 28 The RE-AIM framework was developed to enhance understanding and reporting of the complexity associated with implementing interventions. 29 RE-AIM is a widely used implementation research framework used to understand barriers, challenges, and facilitators at the individual and organizational level when attempting to move research into clinical practice. 30 The RE-AIM dimensions are defined in Table 1 . Reach and effectiveness (RE-) examine individual patient-level factors. 31 Reach evaluates the extent to which the interventions are received by individual patients. Effectiveness considers the impact of the intervention on patient-centered outcomes. Adoption, implementation, and maintenance (AIM) evaluate factors at the level of the organization or clinical setting. 31 Adoption assesses the staff/provider rate of intervention uptake. Implementation evaluates the fidelity with which an intervention is provided. Maintenance can include both patient-and organization-level outcomes and describes the sustainability of implementation over time. Reporting RE-AIM dimensions associated with efforts to implement an intervention can enhance reproducibility and highlight factors that help explain why implementation efforts may accomplish or fall short of their intended impact. 28, 32 The purpose of this study was to examine implementation of the RapidAccess program within 1 integrated health care system using a RE-AIM framework. We considered performance over the first 14 months of the ongoing RapidAccess program by defining and reporting the reach, effectiveness, adoption, and implementation of the program and the maintenance of these dimensions over time.
Methods

Patient Population
Patients were eligible if they had a chief complaint of LBP and called to schedule an appointment with a physiatrist in the UUH outpatient orthopedic center. We included patients who called to schedule care between January 1, 2016, and March 31, 2017. Additional eligibility included coverage by 1 of 2 private insurers with an established policy reimbursing physical therapy without physician referral. These 2 payers comprise approximately 30% of the casemix at the UUH outpatient orthopedic clinic, and about 60% of the privately insured patients at the clinic (exclusive of federal insurance programs, workers' compensation, etc.). Patients were excluded if: (1) they had a specific LBP diagnosis not appropriate for physical therapy; (2) were already being seen in physical therapy; or (3) failed to attend a physiatrist or physical therapist visit after calling to schedule.
RapidAccess Program
To assess RapidAccess eligibility, a script that included a screening algorithm, was developed to screen all individuals calling to schedule an appointment in the physiatry outpatient orthopedic clinic. The script allowed appointment scheduling staff to identify potentially eligible individuals based on their chief complaint and payer. Only patients scheduling a new appointment were potentially eligible. Individuals calling for a new appointment with a chief complaint of LBP with or without radicular symptoms were asked which insurance would be billed for their care. If the payer was 1 of 2 eligible for RapidAccess, the patient was then asked if they would like to schedule a RapidAccess physical therapy appointment with their physiatrist appointment. The scheduler explained that RapidAccess allowed the patient to schedule a physical therapy appointment in the outpatient clinic colocated at the UUH orthopedic center. The scheduler informed the patient that efforts would be made to initiate physical therapy within 72 hours and the physiatrist appointment would be scheduled regardless of participation in RapidAccess. Patients interested in beginning physical therapy via RapidAccess were transferred to the physical therapy scheduler. The results of the screening process and whether the patient accepted participation in RapidAccess were electronically recorded.
The UUH physical therapy clinic reserved new patient evaluation appointments for RapidAccess referrals in order to meet the goal of access within 72 hours. Three different physical therapists provided care for RapidAccess participants. No specific training was provided to these physical therapists other than a reminder to focus on evidence-based management, provide reassurance to patients, and advise patients to stay active and return to normal activities as soon as possible. Interventions were provided at the discretion of the physical therapist. If the physical therapist determined that the patient was not appropriate for physical therapy (eg, red flags or the patient's symptoms warranted pharmacologic pain management), a consultation with physiatry was initiated. Patients were counseled that, if they felt adequate improvement with physical therapy and were confident in their ability to manage their LBP, they should cancel their physiatry appointment. The decision to cancel the physiatry appointment was left to the discretion of the patient.
Variables Collected
All variables used in this project were collected as part of routine procedures in the UUH orthopedic center clinics. Approval for this project was received from the University of Utah Institutional Review Board under exempt status. Scheduling records were used to record if potentially eligible individuals were offered RapidAccess, and if the patient Higher scores represent better physical function. The PROMIS PFCAT has demonstrated concurrent validity and reliability. 35, 36 Correlation with the Oswestry Disability Index 37 , a wellvalidated patient-reported outcome assessing disability in patients with LBP, is high (r = 0.80, P < .05). 37 Although a minimum important difference is not yet established for the PFCAT among patients with LBP, a recent report found a PFCAT change of 4.5 (SD = 7.0) corresponded to patient self-rating of "better" general health, whereas a change of 3.1 (SD = 6.1) corresponded to patient self-ratings of "about the same." 38
Cohort Assembly for Analyses
We assembled the patient cohort for analysis beginning with a review of records from the UUH physiatry outpatient clinic scheduling service. We identified patients calling to schedule a new physiatrist visit for a primary complaint of LBP during the time frame for project inclusion ( January 1, 2016, to March 31, 2017) . For patients with a primary complaint of LBP, we obtained primary payer information from the UUH electronic health record to identify those eligible for RapidAccess (Fig. 2) . We excluded patients with specific diagnoses (fracture, spinal tumor, postsurgical referral, etc.), those already receiving physical therapy, and those who cancelled all appointments and attended neither a physiatrist nor a physical therapy visit. Remaining patients constituted the cohort for further analyses.
Based on scheduling records we recorded RapidAccess participation as not offered, offered but refused, or The sustainability of implementation over time Performance within the reach, adoption, and implementation dimensions over time n Currently receiving physical therapy n ni ue in ivi uals ith chie c plaint calling t sche ule ne ph ysiatrist app int ent n ri ary pa yer n t eligi le r api cc ess e ica re e icare va ntage n ther pr ivate insurer n e icai n r ers C pensa ti n n n i n t atten a physiatrist r physical therapist visit n nclu e in analyses n api ccess pa rticipants n api ccess n nparticipants n ecline par ticipati n n t ere participati n n peci ic iagn sis pinal racture n yn vial cyst n accepted or declined participation. The UUH electronic health record was used to record each patient's age, sex, and primary insurance payer and to identify dates of service for LBP-related provider visits, imaging, and procedure codes.
Patient-reported outcomes are routinely collected at provider visits in the UUH orthopedic center clinics. 33 The Patient-Reported Outcomes Measurement Information System (PROMIS) physical function computer-adapted measure (PFCAT) 34 is collected weekly from patients via self-report using a tablet at physiatrist and physical therapist visits. The PFCAT is reported as a T score with a mean of 50 (SD = 10).
accepted. For patients who accepted RapidAccess, we recorded the date of initiation of physical therapy as the index date. For patients declining or not offered RapidAccess the initial physiatrist visit was the index date. For all patients, we counted the number of days from the scheduling call to the index date as the time to care initiation. We recorded use outcomes for a 6-month period following the index date for all patients. The UUH electronic health record was used to record the number of physical therapy visits, use of lumbar radiographs, advanced imaging (MRI or CT), epidural steroid injections, spine surgeon visits (orthopedic or neurosurgeon), and lumbar surgical procedures occurring in the 6-month follow-up period. For each patient, all available PFCAT scores from provider visits within the 6-month project period were recorded.
Measures of Patient-Level RE-AIM Dimensions
We used the 5 dimensions of the RE-AIM framework to evaluate the process of implementing RapidAccess (Tab. 1). Regarding patient-level dimensions, we examined Reach as the percentage of eligible patients who participated in RapidAccess. We further examined the characteristics of participating patients relative to nonparticipants for characteristics including age, sex, time to care initiation, and physical function at the index date. Effectiveness of RapidAccess was evaluated by comparing health care use outcomes (radiographs, advanced imaging, epidural steroid injections, spine surgeon visit, and surgical procedures) during the 6-month follow-up. For patients participating in RapidAccess and for nonparticipants in RapidAccess, we calculated the change in PFCAT scores from the first to last physical therapy visit. We compared the number of physical therapy visits, duration of physical therapy care (number of days between first and last physical therapy session), and change in PFCAT in patients who participated in RapidAccess with those patients who did not participate in RapidAccess but attended physical therapy after their physiatrist visit.
Measures of OrganizationalLevel RE-AIM Dimensions
For the organizational dimensions of RE-AIM, we evaluated Adoption by examining the percentage of patients
Data Analysis
We reported descriptive statistics for the patient cohort. For the Reach dimension, we used unpaired t tests and chi-square tests to compare RapidAccess participants and nonparticipants (including those refusing and those not offered participation). Effectiveness outcomes were examined using chi-square tests to compare use rates between RapidAccess participants and nonparticipants during the 6-month follow-up period. Changes in PFCAT scores during physical therapy were compared between RapidAccess participants and patients receiving physical therapy after their physiatry visit. We used analysis of covariance to compare change in PFCAT during physical therapy adjusting for initial PFCAT score. We used t tests to compare the number of physical therapy visits and duration of care (days between initial and final physical therapy visit) during the 6-month follow-up period. Descriptive statistics were used to examine Adoption, Implementation, and Maintenance outcomes. Two-tailed tests of significance were set for all analyses.
Results
From January 1, 2016, through March 31, 2017, a total of 1556 unique individuals called to schedule a new visit with a UUH physiatrist for a chief complaint of LBP. Of these, 400 (25.7%) were eligible for RapidAccess and were included in the analyses (Fig. 2) . The primary reasons for noneligibility were the patient's primary payer (90%) and nonattendance at either a physical therapist or physiatry visit (9%). Among included patients, the mean age was 45.5 (SD = 14.4) years, and 229 (57.3%) were female.
Patient-Level RE-AIM Dimension Results
Of the 400 eligible patients, 124 (31.0%) participated in RapidAccess (Reach). Relative to those participating, nonparticipants were older (mean difference = 5.4 years, 95% confidence interval [CI] = 2.4-8.4, P = .001) and had a shorter time from scheduling to physiatry appointment (mean difference = 20.9 days, 95% CI = 14.9-26.8, P < .001) (Tab. 2). There was no difference in participants' sex. PFCAT scores were collected on the index date for 111 (89.5%) RapidAccess participants and 202 (73.2%) nonparticipants. Available index date PFCAT scores indicated comparability between RapidAccess participants and nonparticipants with respect to physical function (mean difference = 0.5, 95% CI = -2.3 to 1.4, P = .63) (Tab. 2). Among the RapidAccess participants, 2 (1.6%) were immediately referred to physiatry. One patient had symptoms of bowel and bladder dysfunction and 1 patient needed pharmacologic pain management.
Use outcomes (Effectiveness) based on RapidAccess status are provided in Table 3 . Compared with nonparticipants, RapidAccess participants were less likely to have lumbar radiographs, advanced imaging, epidural injections, or visits with a spine surgeon (P < .05) over the 6-month follow-up period (Tab. 3). Ten individuals had a spinal surgical procedure within 6 months of the index visit (2 RapidAccess participants, 8 nonparticipants). Four procedures involved lumbar spine fusion (all nonparticipants).
We further examined Effectiveness using changes in PFCAT scores across the physical therapy episode of care for those attending via RapidAccess participation (n = 124) and those referred to physical therapy after their physiatrist visit (n = 96) (Tab. 4). Compared with patients receiving physical therapy following a physiatrist visit, participants in RapidAccess had a similar mean number of physical therapy visits, but a shorter duration of physical therapy care (median duration 42 days for RapidAccess, 49 days for referred patients, P = .045). Of 124 patients accessing physical therapy via RapidAccess, 25 (20.2%) attended a single physical therapy visit. Of the remaining 99 patients attending more than 1 visit, complete PFCAT data were available for 85 (85.9%). Among the 96 patients attending physical 
Discussion
This study used a RE-AIM framework to examine patient-and organizational-level factors influencing the effort to implement an evidence-based care pathway for patients with LBP in 1 integrated health care system. The goal of the RapidAccess program was to better align care for patients with LBP with evidence-based guidelines recommending therapeutic options provided by physical therapists before specialist referral, advanced imaging, and invasive procedures. The RapidAccess program generally produced the desired effects. RapidAccess participants demonstrated improvement in physical function with physical therapist management; a majority (58.9%) cancelled their physiatrist visit, and rates of imaging and injections were lower than for nonparticipants. Additional dimensions of our RE-AIM evaluation indicate areas requiring improvement to realize the optimal impact of the RapidAccess program. In particular, program reach and adoption were suboptimal and challenging to maintain over time.
Implementing evidence-based practice changes is challenging. Planning and evaluating implementation efforts should be based on a framework such as RE-AIM that identifies key issues across levels of multiple domains. 39 Many reporting efforts focus on effectiveness outcomes at the patient level with little attention to issues at the staff and organizational levels or related to the adoption and maintenance of implementation efforts. 40 Attention to multiple levels of implementation outcomes enhances the identification of barriers at levels beyond the patient and could facilitate sustainable practice change. Our use of the RE-AIM framework for evaluating the RapidAccess program highlights several important barriers plus the potential impact of broader implementation.
In the Reach domain, 31.5% of eligible patients enrolled in RapidAccess.
Reach averaged about 40% for the first 6 months then declined. We believe this decline was related to reduced wait times to see a physiatrist. The generally low percentage of patients who enrolled in RapidAccess might reflect overall patient perceptions of physical therapy. We did not track the number of patients being referred by another physician for a physiatry consultation versus those scheduling a first provider visit for LBP. Based on practice patterns in our health system, however, many patients were calling to schedule a first-contact visit, and patient attitudes about the appropriateness of physical therapists in this role might also be reflected in our findings. Patients who were reached by RapidAccess were generally younger and had longer wait times for a physiatry appointment. These findings may reflect perceptions about physical therapy that vary with age and the accessibility to other treatment options. Efforts to educate patients and provide information about likely outcomes based on different care pathways could enhance informed decision-making by patients and increase RapidAccess reach. 41 Such efforts could include education, provided to the patient electronically when patients make appointments through an online scheduling platform, about the benefits of early physical therapy. Partnering with insurance companies to incentivize physical therapist management before physician management may also improve reach.
The low percentage of patients reached by RapidAccess should be evaluated with consideration of the challenges in Adoption. The principal reason for nonparticipation was not at the patient level. Among patients offered RapidAccess, the acceptance rate was 55%. Staff failure to adopt RapidAccess and offer it to eligible patients accounted for a greater proportion of the failure to reach patients. There may be several reasons why adoption was not higher. The RapidAccess process was not well integrated into the scheduling staff's work flow; it relied on staff remembering to use the screening script and offer RapidAccess to appropriate patients. The scheduling staff handle calls for all orthopedic providers and a variety of conditions, not just back pain. Barriers to adoption identified by scheduling staff included the high volume of calls and time constraints, which made applying a specialized screening algorithm challenging. Staff turnover was another barrier to establishing and maintaining adoption. When new scheduling staff were hired, they were not always promptly trained in the RapidAccess screening algorithm, which may have resulted in eligible participants not being offered the program. It is also evident from our adoption metrics (Tab. 2) that adoption was lower when the scheduled physiatry appointment was sooner rather than later, making the need to find a more timely alternative less urgent. Improving adoption and maintenance will require better strategies to integrate the screening process into the work flow of scheduling staff and create an environment that supports physical therapy as the first option for management independent of wait times for physiatry.
Implementation outcomes provide information on the extent to which program elements were provided with fidelity to the intended RapidAccess program. One implementation outcome tracked was fidelity to the goal of scheduling RapidAccess participants with physical therapy within 72 hours of the scheduling call. We achieved this with 59% of participants. Patients' personal schedules and availability of physical therapy appointments accounted for some of the variability in achieving this goal. Although challenging to attain, timeliness of care is an important and patient-centered outcome, specifically for LBP care pathways. Extended wait times reduce patient satisfaction and may increase a patient's fear and catastrophic thinking. 42 For patients with LBP, symptom duration is an important prognostic factor, 43 and initiating evidence-based treatments earlier may result in improved outcomes and shorter total episode duration, as was noted within RapidAccess.
Another implementation goal of the RapidAccess program was for the physical therapist to counsel participating patients that a goal of the program was to provide enough improvement and self-management skills that they would choose to cancel their physiatry appointment. We did not track fidelity of the physical therapist in providing this counsel, but did examine attendance at physiatry appointments for participating patients. We found that 59% of participants cancelled their physiatry appointment. The reasons why patients decided to cancel or to attend their physiatry appointment were not tracked; however, based on communication with the physical therapists involved in the RapidAccess program, it appears that many patients were comfortable proceeding with self-management and cancelling their physiatry appointment. The objective of an evidence-based pathway is coordination of care across multidisciplinary settings and timely resource allocation to appropriate patients. 9 Therefore, patients who attended their physiatry consultation following physical therapy did not represent failures of the pathway, but were instead reflecting the goals of the pathway to follow an evidence-based sequence of receiving physical therapy before a specialist consultation. These patients are presumed to be the subset for whom physiatry consultation was appropriate instead of representing a premature escalation of care. Longer-term systematic follow-up of patients is necessary to evaluate this assumption.
Our outcomes in the Effectiveness domain support the potential benefits of an evidence-based care pathway. We found lower rates of imaging and injections for patients who received physical therapy first, primarily attributable to their not consulting a physiatrist. Functional outcomes were better with no increase in physical therapy use for patients who attended physical therapy as RapidAccess participants relative to those receiving physical therapy after physiatry consultation. This enhanced effectiveness is not surprising as similar results have been reported by other teams making similar efforts to improve the sequence of care for patients with LBP within health systems. [44] [45] [46] The common goal of these efforts is to create a pathway that is likely to result in an individual patient having timely access to the provider who is trained to deliver the type of care appropriate to the patient's clinical circumstances. 9 In the United States, this goal is often forestalled by extended wait times and premature escalation of care to imaging, specialist consultations, and invasive procedures. Thirty-four percent of patients attended physical therapy following a visit with a physiatrist. This percentage likely reflects the local referral practices of the physiatrists for patients not already attending physical therapy.
In the Maintenance domain, the general trend toward diminishing performance of reach and adoption beyond the first 6 months of the project (eAppendix 1, available at https://academic.oup.com/ ptj) reflects the challenges of maintaining the process over time. 
Limitations
This study has important limitations. RapidAccess was implemented in a single health care clinic within a large health care system. As such, the challenges to implementation are specific to this setting and may not apply to other clinics or health care systems. We only included patients who were insured by insurance payers with a history of reimbursing for physical therapist management without a physician's referral, which led to the exclusion of many patients. Our results might have been different if we had included patients from all payers. Furthermore, regional differences in reimbursement policies could influence the enrollment of patients into similar pathways in different insurance markets. The changes between RapidAccess participants and nonparticipants in PFCAT scores should be interpreted with caution. The nonparticipants were generally older, which could have influenced their outcomes. Also, participants were not randomized to either the RapidAccess group or the nonparticipant group. As such, unmeasured patient characteristics are likely to be unequally distributed between the groups, which may have influenced the effectiveness outcomes. Finally, qualitative interviews of the patients, providers, and scheduling staff would have enhanced our understanding of the implementation outcomes.
Conclusion
Any health care system can face unique challenges that impact its ability to maintain newly implemented clinical pathways. Our experience suggests that the implementation of guideline-concordant clinical pathways, such as RapidAccess, could have a positive impact on patient-centered outcomes. The RE-AIM framework helped us to highlight the challenges and barriers to implementation of RapidAccess at both the individual and organizational level. This study leads to several recommendations for future research. Future work should focus on implementing similar alternative pathways for patients with LBP in different health care settings while collecting qualitative outcomes from key stakeholders. Structured interviews and feedback from key stakeholders throughout the implementation process would provide a greater understanding of the limitations in adoption, implementation, and maintenance. Examining methods to improve the implementation process, such as automation of the opportunity to select physical therapy as a first treatment, could improve reach, adoption, and maintenance.
